- This event has passed.
EGFR Resisters research update
March 5 @ 5:00 pm – 6:30 pm ET
Join us for a virtual update with recipients of the 2022 LCRF and EGFR Resisters Research Grant on EGFR-Driven Lung Cancer! This informative webinar will allow participants an opportunity to hear from grantees and ask questions about their research projects. Please RSVP below and watch your email for the Zoom details.
Speakers
Swarnali Acharyya, PhD
Columbia University Medical Center
Research project:
Drugging the S100A9-Retinoic acid pathway: companion biomarker and therapy
Luke Hoeppner, PhD
University of Minnesota, Twin Cities
Research project:
Predictive biomarkers and new therapeutic strategies to prevent EGFR TKI-refractory lung cancer progression
Jonathan Ostrem, MD, PhD
University of California, San Francisco
Research project:
Enhancing the precision of targeted therapies for EGFR-mutant lung cancer
Add to Google Calendar